secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2025-07-21T23:59:59+00:00
Accession:  0001562762-25-000166
Event type: leadership
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical CEO Scavilla resigns; Pfeil named CEO; preliminary Q2 sales $745.3M (+18% YoY)
--------------------------------------------------------------------------------

- Daniel Scavilla resigned as President and CEO effective July 18, 2025 to pursue another opportunity; no disagreement cited.
- Keith Pfeil, formerly COO/CFO, appointed President and CEO effective July 18, 2025; also joins Board.
- Kyle Kline appointed CFO effective July 18, 2025; previously SVP of Finance.
- Preliminary Q2 2025 sales ~$745.3M, up 18.4% as reported; base business ex-Nevro up 4.8% day-adjusted.
- Full-year 2025 guidance reaffirmed: revenue $2.80–$2.90B, non-GAAP EPS $3.00–$3.30.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000156276225000166/0001562762-25-000166-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000156276225000166/gmed-20250718x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-25-000166

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer